News | April 17, 2025
Fortis Healthcare launches Fortis Institute of Genomic Medicine
Genomics is transforming the future of modern medicine and treatment modalities across specialties
Genomics is transforming the future of modern medicine and treatment modalities across specialties
The National IP Awards recognize outstanding contributions to India’s innovation economy through effective IP creation and commercialization
The product will be launched in Q1FY26
Mantri will replace V. S. Mani, Executive Director & Global Chief Financial Officer of the company as he has conveyed his decision to opt for early retirement
Findings likely to generate hypotheses about potential new uses of drugs
The portfolio includes branded injectable cephalosporines for infectious diseases
New trontinemab data continue to support rapid and deep, dose-dependent reduction of amyloid plaques in Phase Ib/IIa Brainshuttle AD study
The acquisition of MDxK further strengthens the Business Unit’s position in the molecular diagnostics market
Dupixent (dupilumab) approved as the first-ever biologic medicine in Japan for patients with Chronic Obstructive Pulmonary Disease (COPD)
The freshly infused capital will primarily be deployed towards expansion and research & development
Subscribe To Our Newsletter & Stay Updated
